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Chronic inflammation and γδ T Cells
Nathan S. Fay, Emily C. Larson and Julie M. Jameson*
Department of Biological Sciences, California State University, San Marcos, San Marcos, CA, USA
The epithelial tissues of the skin, lungs, reproductive tract, and intestines are the
largest physical barriers the body has to protect against infection. Epithelial tissues 
are woven with a matrix of immune cells programed to mobilize the host innate and 
adaptive immune responses. Included among these immune cells are gamma delta T 
lymphocytes (γδ T cells) that are unique in their T cell receptor usage, location, and 
functions in the body. Stress reception by γδ T cells as a result of traumatic epithelial 
injury, malignancy, and/or infection induces γδ T cell activation. Once activated, γδ T 
cells function to repair tissue, induce inflammation, recruit leukocytes, and lyse cells. 
Many of these functions are mediated via the production of cytokines and growth fac-
tors upon γδ T cell activation. Pathogenesis of many chronic inflammatory diseases 
involves γδ T cells; some of which are exacerbated by their presence, while others are 
improved. γδ T cells require a delicate balance between their need for acute inflam-
matory mediators to function normally and the detrimental impact imparted by chronic 
inflammation. This review will focus on the recent progress made in understanding 
how epithelial γδ T cells influence the pathogenesis of chronic inflammatory diseases 
and how a balance between acute and chronic inflammation impacts γδ T cell function. 
Future studies will be important to understand how this balance is achieved.
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γδ T CeLLS PLAY ReGULATORY ROLeS in A vARieTY 
OF ePiTHeLiAL TiSSUeS
Skin
Resting epidermal gamma delta T lymphocytes (γδ T cells) exhibit a dendritic morphology and 
hence are referred to as  dendritic epidermal T cells (DETCs). DETCs express canonical γδ T cell 
receptors that recognize an as yet unidentified antigen without requiring classical major histocom-
patibility comple (MHC) presentation (1, 2). Stress, trauma, tumorigenesis, and/or some infections 
(3) of local keratinocytes induce activation of the γδ T  cell receptor (TCR) causing DETCs to 
round-up and produce growth factors (4–6). In order for DETCs to recognize local stress signals 
Abbreviations: γδ T cells, gamma delta T lymphocytes; AHR, airway hyperresponsiveness; CAR, coxsackieviruses and adeno-
virus receptor; CCR9, C-C chemokine receptor type 9; CD100, cluster of differentiation 100; CD3, cluster of differentiation 3; 
CD45RA, cluster of differentiation 45RA; CLA, cutaneous lymphocyte antigen; DETC, dendritic epidermal T cells; Egr3, Early 
growth response 3; HFD, high fat diet; IBD, inflammatory bowel disease; IEL, intraepithelial lymphocyte; iNOS, inducible 
nitric oxide synthase; JAML, junction adhesive molecule-like protein; KGF-1, keratinocyte growth factor 1; MHC, major 
histocompatibility complex; NKG2D, NK receptor group 2 member D; PBMC, peripheral blood mononuclear cell; TCR, T cell 
receptor; TL1A, TNF-like protein 1A; TRAIL-R1, Tumor necrosis factor-related apoptosis-inducing ligand R1; TRAIL-R2, 
Tumor necrosis factor-related apoptosis-inducing ligand R2; UC, ulcerative colitis.
FiGURe 1 | Stress-related signals activate γδ T cells following trauma to epithelial tissues (A). CAR–JAML interaction between keratinocytes and γδ T cells 
(B) costimulates γδ T cell activation. Activated γδ T cells secrete growth factors to initiate tissue repair (C) and trigger macrophage (mφ) recruitment to assist in 
inflammation (D). γδ T cells proximal to the wound site have fewer dendrites and appear more rounded (e).
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and become activated, additional costimulatory mechanisms 
must be triggered. These signals include (1) ligation of the cluster 
of differentiation 100 (CD100) receptor by Plexin B2 and (2) 
ligation of junction adhesive molecule-like protein (JAML) by 
coxsackieviruses and adenovirus receptor (CAR) (7, 8). Figure 1 
illustrates this interaction by showing that stress-related signals 
from damage to epithelial tissues (Figure  1A) and costimula-
tion between keratinocytes and γδ T cells (Figure  1B) trigger 
growth factor production (Figure 1C) and chemokine secretion 
(Figure  1D) that ultimately assist in wound repair. Using a γδ 
TCR tetramer, it has been shown that the antigen recognized by 
DETCs is upregulated several hours post-wounding just prior to 
DETC activation and rounding (6).
Dendritic epidermal T cells participate in wound healing by 
releasing cytokines, chemokines, and growth factors that regulate 
leukocyte recruitment, inflammation, and keratinocyte prolif-
eration (4, 9). It is known that inflammation in burned epithelial 
tissues stimulates the activity of inducible nitric oxide synthase 
(iNOS) leading to increased production of nitric oxide – a potent 
vasodilatory cytokine (10). Cytokine production was examined 
when an epidermal burn was applied to mice with or without 
γδ T cells (11). In each of these strains, a peak in production 
was noted at 3 days post-burn, which coincided with peak tissue 
inflammation. During this peak in inflammation, wild-type mice 
exhibited an 18-fold increase in iNOS expression when com-
pared to unburned mice, while iNOS expression had increased 
only 20% in γδ T cell-deficient mice (TCRδ −/− mice) (11). Mice 
administered an iNOS inhibitor failed to adequately repair 
burned epithelial tissues, suggesting a major role for DETCs in 
iNOS production in wound inflammation (11).
A subsequent study found that γδ T cells influence the recruit-
ment of Th1, Th2, and Th17 cells to a burn site (12). When mice 
were subjected to an epidermal burn, Rani et  al. observed a 
significant influx in cluster of differentia tion 3 (CD3+) T cells 
at the burn site as compared with unburned sham mice. At 
7 days post-burn, γδ T cells expressing IFN-γ increased 3-fold, 
while IL-10- and IL-17-producing γδ T  cells increased 9-fold 
and 20-fold, respectively. These regulatory roles of γδ T cells in 
the skin suggest that inflammation can be skewed to improve or 
impair wound healing (12). It is unknown if epidermal or dermal 
γδ T cells are responsible, but it may be a combination of both. γδ 
T cell regulatory functions are likely to be altered in environments 
with preexisting chronic inflammation as in obesity or aging.
intestine
Intraepithelial γδ T cells comprise approximately 50% of total 
CD3+ T cells in the small intestine. The role of γδ intraepithelial 
lymphocytes (IELs) in the intestine has been somewhat contro-
versial. Some populations of γδ IELs protect intestinal epithelial 
cells through the production of growth factors, while other γδ 
IEL populations inflict potentially detrimental effects. Unlike 
the anchored γδ T cells of the skin, γδ IELs in the intestine have 
the ability to migrate throughout the intestinal epithelia and the 
lamina propria by an occludin-dependent mechanism –  allowing 
γδ T cells to survey the entire villous epithelium (13, 14). Knockout 
of occludin in mouse γδ IELs in vivo leads to a deficiency in γδ 
T cell mobility within the intestinal epithelium, and thus a reduc-
tion in intestinal γδ IEL number (14). The presence of TNF-α 
also seems to limit γδ IEL migration patterns; however, it does 
so while increasing γδ IEL motility within the epithelium (14). 
This may represent an acute inflammatory response that serves 
to focus γδ IELs to the site of damage or infection.
Intestinal γδ IELs regulate tissue homeostasis and repair in the 
epithelium. When activated, γδ T cells in the intestinal epithelium 
produce keratinocyte growth factor 1 (KGF-1, also known as 
FGF-7) (14). KGF-1 acts on the intestinal epithelium to induce 
epithelial cell proliferation and repair of the epithelium, as needed 
(15, 16). Mice lacking γδ T cells, TCRδ−/− mice, experience 
increased susceptibility to DSS-induced colitis and a reduced 
ability to repair damaged epithelia compared to wild-type mice 
(15, 16). γδ T cells also participate in the maintenance of other 
intestinal features that regulate barrier function. In TCRδ−/− mice, 
mucus-secreting goblet cells are significantly reduced in number 
and the intestinal crypt lengths are shortened (16). Thus, γδ 
T cells are important for the maintenance of the intestinal barrier 
and restoration upon damage.
Inflammatory mediators are likely to impact γδ IEL 
function in the intestine. TNF-like protein 1A (TL1A) 
is a pro-inflammatory cytokine from the TNF cytokine 
family, which is found in high concentrations in mouse 
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models of inflammatory bowel disease (IBD) (17). 
TL1A knockout mice exhibit fewer γδ IELs as compared to wild-
type mice (17). It is suggested that TL1A regulates the infiltration 
and maintenance of γδ IELs in the intestinal epithelium (17). It is 
unknown how the chronic production of inflammatory mediators 
would impact γδ IEL function or maintenance in the intestine.
Lungs
Pulmonary epithelial γδ T cells also contribute to the main-
tenance of barrier integrity and to mucosal immunity in the 
lungs. At birth, mouse Vγ6+ T cells from the thymus seed the 
lung; however, at 3  weeks of age, Vγ4+ T cells become more 
prominent, followed by Vγ5+ and Vγ7+ T cells (18). γδ T cells 
preferentially colonize pulmonary epithelial tissues to promote 
epithelial growth, regulate allergic airway hyper-reactivity by 
Th2 cells, regulate inflammatory responses during infection, and 
more (18). When traumatic hemorrhage is induced in the lungs 
of mice, pulmonary γδ T cells regulate the infiltration of both αβ 
T cells and myeloid-derived suppressor cells into the pulmonary 
epithelium while also increasing their own numbers (19). Recent 
studies have focused on the IL-17-producing ability of lung γδ T 
cells in regulating the outcome of disease.
IL-17-producing pulmonary intraepithelial γδ T cells require 
microbiota to function and confer antitumor activity (20). 
Cheng et  al. examined γδ T cell populations in mice treated 
with antibiotics that were then challenged by an induction of 
Lewis lung carcinoma or melanoma. Treatment with antibiotics 
reduced resident populations of bacteria in the lungs of the mice; 
however, mice receiving the antibiotic treatment also experienced 
a decreased number of pulmonary epithelial IL-17-producing γδ 
T cells (20). The study found that regardless of which bacterial 
population was inhibited in the lungs of these mice, the absence 
of commensal bacteria was enough to inhibit IL-17-producing 
γδ T cell antitumor capabilities in the pulmonary epithelium. 
As a result, these antibiotic-treated mice became susceptible to 
lung tumors. The antitumor response could be restored when 
the mice that were treated with antibiotics received a transplant 
of pulmonary intraepithelial γδ T cells from healthy mice never 
treated with antibiotics (20).
The mechanism by which γδ T cells prevent human lung 
cancer involves the synthesis of ligands from the TNF family 
of cytokines. Tumor necrosis factor-related apoptosis-inducing 
ligand (TRAIL) synthesis by γδ T cells in the lungs trigger lysis 
of cancer cells expressing TRAIL-R2, or occasionally TRAIL-R1 
(21). Stimulation with NK receptor group 2 member D (NKG2D) 
increases TRAIL production and enhances the ability of γδ T cells 
to kill lung cancer cells (21). TNFα induces the expression of 
IL-6 and IL-23, which are required for full IL-17 expression in γδ 
T cells of the lung. When mice deficient in TNFα are challenged 
with ozone, to induce pulmonary damage, they exhibit decreased 
IL-17 production by γδ T cells and a reduced inflammatory 
response (22).
Recent studies have increased our understanding of how IL-17 
production in γδ T cells is regulated. Early growth response 3 
(Egr3) is a transcription factor activated by mitogens that 
negatively regulates the activation of T cells and renders the Th1 
T cell population unresponsive (23). Though Egr3 limits Th1 cell 
activation and responses, it promotes γδ T cell growth and pro-
inflammatory IL-17 production. Mice engineered to overexpress 
Egr3 were found to experience a fivefold increase in splenic 
and pulmonary γδ T cell numbers compared to wild-type mice, 
indicating that Egr3 plays a crucial role in maintaining γδ T cell 
populations (23). Mice overexpressing Egr3 were then given 
pulmonary fibrosis to study inflammation and IL-17 expression. 
It was found that mice with Egr3 overexpression exhibit greater 
inflammation and fibrosis of their lungs and consequently expe-
rience a lower rate of survival than wild-type mice expressing 
normal levels of Egr3 (23). This suggests that IL-17-producing 
pulmonary γδ T cells perform a key pro-inflammatory role 
that can be harmful. Therefore, IL-17-producing pulmonary γδ 
T cells govern a fine balance between the underproduction and 
overproduction of inflammatory responses in the lungs.
γδ T CeLLS in CHROniC inFLAMMATORY 
DiSeASeS
Obesity and Type 2 Diabetes
Human Vγ9Vδ2 T cells (also known as Vγ2Vδ2 T cells) are found 
predominantly in blood and lymphoid tissues, where some of 
the many varieties of Vγ9Vδ2 T cells act as first responders to 
pathogens (24–26), cell stress (26), and cancer (25, 27). Upon 
activation, Vγ9Vδ2 T cells respond by producing cytokines, 
performing cytolysis, and proliferating. Obese individuals are at 
great risk for systemic inflammation, which can lead to type 2 
diabetes, cardiac disease, and increased susceptibility to infec-
tion (28). Once systemic inflammation becomes chronic, obese 
patients exhibit a reduced number of Vγ9Vδ2 T cells. This reduc-
tion is inversely proportionate to their body mass indices (29). 
The remaining Vγ9Vδ2 T cells are significantly reduced in their 
ability to secrete IFN-γ during viral infections like influenza and 
possess a differential bias toward mature T effector memory 
cluster of differentiation 45RA (CD45RA+) cells. As summarized 
in Figure  2, chronic inflammatory conditions pose significant 
pathophysiological implications on γδ T cell function. Recent 
in  vitro experiments are already showing that it is possible to 
rescue Vγ9Vδ2 T cell function with the addition of IL-2, which 
restores Vγ9Vδ2 T cell cytokine production (29).
Studies in murine models of obesity have identified similarly 
reduced γδ T cell numbers in the skin of obese mice (30). 
In  leptin receptor-deficient (db/db) mice, epidermal γδ T cell 
numbers were not significantly different from their db/+ lean 
counterparts until 6  weeks of age. For the next 8  weeks, the 
γδ T cell numbers in db/db mice fell to half the number of γδ 
T cells found in db/+ mice (30). A concurrent wound healing 
study found that the skin γδ T cells of obese db/db mice exhibit 
a reduced ability to produce cytokines and growth factors at 
the wound site (26). The dysfunctional γδ T cells in wounded 
obese db/db mice expressed substantially less TGF-β than lean 
wounded mice. Most remarkably, when systemic TNFα levels 
were reduced in obese db/db mice using neutralizing anti-
TNF-α antibodies, their epidermal γδ T cells demonstrated a 
significant improvement in function (30). Similarly, γδ T cells 
FiGURe 2 | γδ T cells under chronic inflammatory conditions show reduced activity, contributing to multiple pathophysiological issues.
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in the lungs of obese mice produce less IL-17 than γδ T cells in 
the lungs of their lean counterparts in response to ozone (22). 
Regardless of whether obesity in mice is caused by leptin recep-
tor deficiency (db/db) or high fat diet (HFD – 60% kcal from 
fat), the loss of skin γδ T cells in obesity results in a reduction 
in keratinocyte number in the basal layer due to premature 
keratinocyte differentiation and proliferation (31). Together, 
these studies reveal the similarly detrimental impact of chronic 
inflammation in obesity on γδ T cell populations in humans and 
in mouse models of obesity.
Psoriasis
Psoriasis is a hyperproliferative autoimmune disorder in which 
keratinocytes form thick, scaly patches on the skin. Mouse 
IL-23-producing Langerhans cells are responsible for recruit-
ing IL-17A-producing γδ T cells, which stimulate the growth of 
keratinocytes and lead to psoriatic sores (32). TNF-α produced 
by macrophages also stimulates γδ T cells in psoriatic environ-
ments, leading to an increase in IL-17A (33). Not only do local 
epidermal γδ T cells respond to these cytokines but circulating 
γδ T cells in the blood are also affected. In humans, Vγ9Vδ2 
T cells are significantly fewer in number in psoriatic patients, as 
compared to healthy individuals (n = 32, p < 0.01) (34). Upon 
assessing the phenotype of Vγ9Vδ2 T cells, it was found that 
the number of cells carrying the pro-inflammatory cutaneous 
lymphocyte antigen (CLA+) skin-homing marker was reduced 
in patients with psoriasis compared to non-psoriatic controls, 
whereas the number of CLA− Vγ9Vδ2 T cells was similar for 
each (34). The reduction in circulating Vγ9Vδ2 T cells with 
skin-homing receptors suggests that these cells have already 
infiltrated the skin. The harmful activity of γδ T cells in 
patients with psoriasis demonstrates how pro-inflammatory 
γδ T cells can potentially exacerbate chronic conditions and 
illustrates how future γδ-related treatments may face complex 
side effects.
inflammatory Bowel Disease
There are mixed reports about the role γδ T cells play in IBD. 
Research exploring the effects of IBD on peripheral blood 
mononuclear cells (PBMCs) in humans has demonstrated that 
although IBD patients exhibit no significant change in their num-
ber of activated CD3+ T cells, IBD patients possess a fourfold 
increase in circulating activated γδ T cells (35). γδ T cell activa-
tion in ulcerative colitis (UC) patient PBMCs was 2.5× greater 
than in controls without UC, and γδ T cell activation in Crohn’s 
disease patient PBMCs was over 10× greater than in controls (35). 
Further research found that a local increase in γδ T cell number 
is associated with IBD, as tissue samples collected from IBD-
involved and non-involved regions of the same patients showed 
that IBD-involved regions experienced a fivefold increase in γδ 
T cells per gram of tissue (36).
A recent study compared gut-homing γδ T cells from healthy 
individuals with those of patients affected by UC and Crohn’s 
disease. Their findings indicated that patients with active UC and 
Crohn’s disease had a significant increase in the expression of C-C 
chemokine receptor type 9 (CCR9) (37). CCR9 (also known as 
CDw199) is a chemokine receptor and gut-homing marker located 
on circulating γδ T cells, which regulates cell migration. The same 
study also found that individuals with UC and Crohn’s disease had 
markedly reduced CD45RO (a protein tyrosine phosphatase and 
memory marker) expression on circulating γδ cells compared to 
healthy individuals (p < 0.0001). These circulating gut-homing 
cells may account for the common recurrence of UC and Crohn’s 
disease in patients (37).
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Frontiers in Immunology | www.frontiersin.org May 2016 | Volume 7 | Article 210
Asthma
Murine models of asthma suggest that IL-17A production by γδ 
T cells is anti-inflammatory and decreases the likelihood that 
a patient will experience airway hyperresponsiveness (AHR) 
(38). Another study found that the positive effect IL-17 has on 
the regulation of asthma in mice depends on the level of IL-17 
attained (39). Low levels of IL-17 in conjunction with IL-13 
are found to exacerbate asthma, while high levels of IL-17 with 
IL-13, are found to resolve the inflammation and resolve AHR 
(39). Patients with asthma have similar numbers of γδ T cells in 
their sputum, peripheral blood cells, and bronchoalveolar lav-
age as healthy patients, suggesting that asthmatic inflammation 
is not caused by an excess of γδ T cells (40). Given the variety 
of γδ T cells found throughout the body, it may be that multiple 
populations of γδ T cells interact to balance pulmonary IL-17 
levels. Achieving a balance between γδ T cell populations that 
exacerbate inflammation and γδ T cell populations that resolve 
inflammation may be the key to controlling inflammation in 
the lungs.
COnCLUSiOn
The innate and adaptive immune systems are bridged by γδ T cells, 
which serve as the guardians of the epithelium against trauma, 
infection, and other forms of damage. Epithelial barriers are 
critically important to the protection and health of the organism. 
γδ T cells are responsible for maintaining the homeostasis of the 
epithelium via the production of secreted factors, which can act 
in a paracrine manner to sustain a large impact. In this manner, 
γδ T cells not only modulate inflammation but also are sensitive 
to changes in the cytokine milieu caused by chronic inflammatory 
diseases. While cytokines produced by γδ T cells are necessary for 
the health of the tissues and cells, in high concentration these 
factors can yield chronic inflammation. Continued research is 
needed to elucidate the complexities of γδ T cell activation in 
chronic inflammation as well as the roles they play in disease 
pathogeny.
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